Clinical Trial Update: GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients [Phase 2, Phase 3]

View source ↗

Summary

This is a Phase 2/3 clinical trial assessing a gonadotropin-releasing hormone agonist together with letrozole for non-obese, progestin-insensitive endometrial c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Endometrial Hyperplasia
• Endometrial Cancer

Drugs mentioned

• Gonadotropin-releasing hormone agonist
• Letrozole (letrozole)

Snippet

Sponsor: Xiaojun Chen | Conditions: Endometrial Neoplasms, Atypical Endometrial Hyperplasia | Phase 2, Phase 3 | Status: RECRUITING